Clinical trial
MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
NCT00563433 is registered in ClinicalTrials.gov with Abeona Therapeutics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
- Lead sponsor
- Abeona Therapeutics, Inc
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 1994
- Completion date
- July 31, 1996
- Enrollment
- 342 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcers